tiprankstipranks
Genmab A/S (GMAB)
NASDAQ:GMAB
US Market

Genmab (GMAB) Income Statement

Compare
605 Followers

Genmab Income Statement

Last quarter (Q3 2024), Genmab's total revenue was kr5.54B, an increase of 16.78% from the same quarter last year. In Q3, Genmab's net income was kr1.27B. See Genmab’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
kr 16.47Bkr 14.60Bkr 8.48Bkr 10.11Bkr 5.37B
Gross Profit
kr 16.25Bkr 14.60Bkr 8.48Bkr 10.11Bkr 5.37B
Operating Expenses
kr 10.93Bkr 8.24Bkr 5.46Bkr 3.80Bkr 2.73B
Depreciation and Amortization
kr 240.00Mkr 290.00Mkr 250.00Mkr 246.00Mkr 139.00M
EBITDA
kr 5.56Bkr 7.04Bkr 3.15Bkr 6.54Bkr 2.78B
Operating Income
kr 5.32Bkr 6.36Bkr 3.02Bkr 6.31Bkr 2.64B
Other Income/Expenses
kr 316.00Mkr 768.00Mkr 965.00Mkr -409.00Mkr 221.00M
Pretax Income
kr 5.64Bkr 7.04Bkr 3.98Bkr 5.90Bkr 2.86B
Net Income
kr 4.35Bkr 5.45Bkr 2.96Bkr 4.76Bkr 2.17B
Per Share Metrics
kr ―kr ―kr ―kr ―kr ―
Basic EPS
kr 66.02kr 8.34kr 4.52kr 7.30kr 3.44
Diluted EPS
kr 66.02kr 8.26kr 4.48kr 7.22kr 3.40
Weighted Average Shares Outstanding
65.92M 653.87M 653.96M 651.79M 629.63M
Weighted Average Shares Outstanding (Diluted)
65.91M 660.10M 660.46M 658.86M 636.37M
Currency in DKK

Genmab Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis